| Citation: | CHEN Ling, LYU Daping, YAO Ming, WANG Yongquan, WANG Ling. Association between the ratio of non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio and severe intracranial/extracranial atherosclerotic stenosis[J]. Chinese Journal of General Practice, 2025, 23(9): 1484-1487. doi: 10.16766/j.cnki.issn.1674-4152.004160 |
| [1] |
LI S Y, JING J, LI J J, et al. Elevated hs-CRP and symptomatic intracranial/extracranial artery stenosis predict stroke recurrence after acute ischemic stroke or TIA[J]. J Atheroscler Thromb, 2023, 30(6): 601-610. doi: 10.5551/jat.63512
|
| [2] |
GUTIERREZ J, TURAN T N, HOH B L, et al. Intracranial atherosclerotic stenosis: risk factors, diagnosis, and treatment[J]. Lancet Neurol, 2022, 21(4): 355-368. doi: 10.1016/S1474-4422(21)00376-8
|
| [3] |
YU H X, LI H X, CUI C, et al. Association between blood microplastic levels and severity of extracranial artery stenosis[J]. J Hazard Mater, 2024, 480: 136211. DOI: 10.1016/j.jhazmat.2024.136211.
|
| [4] |
XIE Y, LIU Z X, DAN B T, et al. Associations of neutrophil-to-lymphocyte ratio with intracranial and extracranial atherosclerotic stenosis[J]. Front Neurol, 2022, 13: 966022. DOI: 10.3389/fneur.2022.966022.
|
| [5] |
GAO P, WANG T, WANG D M, et al. Effect of stenting plus medical therapy vs medical therapy alone on risk of stroke and death in patients with symptomatic intracranial stenosis: the CASSISS randomized clinical trial[J]. JAMA, 2022, 328(6): 534-542. doi: 10.1001/jama.2022.12000
|
| [6] |
WANG B X, LI L Y, TANG Y, et al. Changes in non-high-density lipoprotein to high-density lipoprotein ratio (NHHR) and cardiovascular disease: insights from CHARLS[J]. Lipids Health Dis, 2025, 24(1): 112. DOI: 10.1186/s12944-025-02536-3.
|
| [7] |
MA H X, CHEN H Q, WANG P C. Association between non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (NHHR) and stroke among adults in the USA: a cross-sectional NHANES study[J]. Biomed Environ Sci, 2025, 38(1): 37-46.
|
| [8] |
LIU Z Z, LIN X M, ZENG L X, et al. Elevated non-HDL-C/HDL-C ratio increases the 1-year risk of recurrent stroke in older patients with non-disabling ischemic cerebrovascular events: results from the Xi' an Stroke Registry Study of China[J]. BMC Geriatr, 2023, 23(1): 410. DOI: 10.1186/s12877-023-04102-x.
|
| [9] |
WANG A R, LI Y P, ZHOU L, et al. Non-HDL-C/HDL-C ratio is associated with carotid plaque stability in general population: a cross-sectional study[J]. Front Neurol, 2022, 13: 875134. DOI: 10.3389/fneur.2022.875134.
|
| [10] |
QIN G M, TU J F, ZHANG C J, et al. The value of the apoB/apoAΙ ratio and the non-HDL-C/HDL-C ratio in predicting carotid atherosclerosis among Chinese individuals with metabolic syndrome: a cross-sectional study[J]. Lipids Health Dis, 2015, 14: 24. DOI: 10.1186/s12944-015-0023-4.
|
| [11] |
LIU L Q, LIU S H, LIAO Y C, et al. Association of cumulative non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio with the risk of cardiometabolic disease[J]. Front Cardiovasc Med, 2024, 11: 1500025. DOI: 10.3389/fcvm.2024.1500025.
|
| [12] |
LIU M J, PEI J Y, ZENG C, et al. Association of non-high-density lipoprotein cholesterol/high-density lipoprotein cholesterol ratio with cardiovascular outcomes in patients with type 2 diabetes mellitus: evidence from the ACCORD cohort[J]. Diabetes Obes Metab, 2025, 27(1): 300-311. doi: 10.1111/dom.16018
|
| [13] |
管晶晶, 时鹏, 李保伍, 等. 颈动脉粥样硬化斑块超声联合血脂指标对心血管疾病的预测价值评估[J]. 中华全科医学, 2022, 20(8): 1376-1379. doi: 10.16766/j.cnki.issn.1674-4152.002601
GUAN J J, SHI P, LI B W, et al. Value evaluation of carotid atherosclerotic plaque ultrasound combined with blood lipid index in predicting cardiovascular disease[J]. Chinese Journal of General Practice, 2022, 20(8): 1376-1379. doi: 10.16766/j.cnki.issn.1674-4152.002601
|
| [14] |
INIA J A, VAN NIEUWKOOP-VAN STRAALEN A, JUKEMA J W, et al. Efficacy of a novel PCSK9 inhibitory peptide alone and with evinacumab in a mouse model of atherosclerosis[J]. J Lipid Res, 2025, 66(3): 100753. DOI: 10.1016/j.jlr.2025.100753.
|
| [15] |
NAMITOKOV A, KARABAKHTSIEVA K, MALYAREVSKAYA O. Inflammatory and lipid biomarkers in early atherosclerosis: a comprehensive analysis[J]. Life (Basel), 2024, 14(10): 1310. DOI: 10.3390/life14101310.
|
| [16] |
ZHANG P, JIN M Y, ZHANG L, et al. Berberine alleviates atherosclerosis by modulating autophagy and inflammation through the RAGE-NF-κB pathway[J]. Front Pharmacol, 2025, 16: 1540835. DOI: 10.3389/fphar.2025.1540835.
|
| [17] |
FU M X, LI Q M, QIAN H, et al. Exendin-4 intervention attenuates atherosclerosis severity by modulating myeloid-derived suppressor cells and inflammatory cytokines in ApoE(-/-) mice[J]. Int Immunopharmacol, 2024, 140: 112844. DOI: 10.1016/j.intimp.2024.112844.
|
| [18] |
CHANG J, LIU B, CHENG Y X, et al. Effect of repaglinide on blood glucose, endothelial function, lipid metabolism, and inflammatory reaction in a rat model of atherosclerosis[J]. Dose Response, 2020, 18(2): 710599702. DOI: 10.1177/1559325820918762.
|